Table 3 Model build performed for infant neurologic morbidity without interference.

From: Assessing for prenatal risk factors associated with infant neurologic morbidity using a multivariate analysis

Variable

Parameter estimate

Standard error

Odds ratio (95% CI)

P-value

Intercept

−2.10

0.68

NA

0.002

Insurance

 Medi-Cal

0.38

0.3

1.47 (0.81–2.66)

0.2088

 Other

1.85

0.75

6.38 (1.48–27.48)

0.0129

Gestational age

 <25 weeks

2.9

0.77

18.24 (4.05–82.16)

0.0002

 25–31 weeks

1.95

0.39

6.99 (3.24–15.09)

<0.0001

 32–36 weeks

1.15

0.38

3.17 (1.51–6.65)

0.0023

VEGFR3

−0.27

0.12

0.76 (0.61–0.96)

0.0201

IL12p70

 <25th percentile

1.66

0.53

5.24 (1.86–14.78)

0.0018

 >75th percentile

1.36

0.62

3.9 (1.17–13.05)

0.0272

IL-15

 <25th percentile

−0.9

0.49

0.41 (0.16–1.06)

0.0664

 >75th percentile

−1.34

0.54

0.26 (0.09–0.76)

0.0139

IL-5

 <25th percentile

−1.5

0.52

0.22 (0.08–0.62)

0.0038

 >75th percentile

−1.5

0.59

0.22 (0.07–0.70)

0.0104

MIP1A

 <25th percentile

1.39

0.41

4.01 (1.80–8.90)

0.0007

 >75th percentile

0.22

0.42

1.25 (0.54–2.86)

0.6025

  1. AUC 0.802 (0.747–0.856).
  2. References for categorical variables: Insurance - private; Gestational age - 37–42 weeks; M-IL12p70, IL-15, IL-5, MIP1A - 25–75th percentile; All biomarkers natural log transformed.
Back to article page